We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

IRadimed Corporation

IRadimed manufactures MRI IV infusion systems and MRI patient monitoring systems. It has an experience of 60+ years i... read more Featured Products: More products

Download Mobile App




Novel Infusion Pump Allows Drug Delivery During MRI Scans

By HospiMedica International staff writers
Posted on 04 Jan 2017
A novel infusion pump compatible with magnetic resonance imaging (MRI) devices enables patients dependent on intravenous (IV) medication to undergo scanning.

The MRidium 3860+ infusion pump system is designed to provide a seamless approach that enables accurate, safe, and dependable IV medication and fluid delivery before, during, and after an MRI scan. More...
A broad range of infusion rates support differing patient needs, including low levels for sedating children and infants in order to immobilize them during an MRI scan, mid-levels for continued IV infusion of medications to critically-ill patients, and high levels in the event of emergency situations.

The system incorporates a non-magnetic motor with a broad range of fluid flow control--from 0.1 to 1,400 mL per hour in order--to ensure the safe and predictable delivery of IV fluids during the MRI procedure. The IV infusion pump system also includes a proprietary single-use IV tubing sets, a non-magnetic pole, and a lithium battery, allowing it to be operated dependably in the presence of 0.2T to 3T magnets, up to a fully operational 10,000 gauss-line. Optional upgrades include a remote control, a sidecar, and an oxygen saturation pulse oximetry (SpO2) monitor.

The device also includes dose error reduction system (DERS) software, which enables users to create a unique drug library and establish nominal values and limits for dose and concentration for specified infusion protocols. With DERS, patient safety and user convenience are supported by user-programmed infusion hard (maximum and minimum) and soft (user confirmed) limits. The MRidium 3860+ infusion pump system is a product Iradimed (Winter Springs, FL, USA), and has been approved by the U.S. Food and Drug Administration (FDA).

“We have demonstrated that our IV pump and development processes meet the high standards established by FDA,” said Roger Susi, President and Chief Executive Officer of the Company. “With this clearance behind us, we are now able to allocate our full resources to finalizing the development of our MRI compatible patient vital signs monitoring system, and continue planning for its successful launch.”

Related Links:
Iradimed


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.